{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:21:20Z","timestamp":1794543680400,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ahj.2008.06.029","type":"journal-article","created":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T04:41:30Z","timestamp":1222231290000},"page":"855-863.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":225,"title":["Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis"],"prefix":"10.1016","volume":"156","author":[{"given":"Shinya","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"R\u00f6ther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiau-Suong","family":"Liau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Corbal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Aichner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.06.029_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.06.029_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2004.06.080","article-title":"Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.06.029_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.amjmed.2006.06.042","article-title":"Coronary ischemic events after first atrial fibrillation: risk and survival","volume":"120","author":"Miyasaka","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.06.029_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.06.029_bib7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.06.029_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.amjmed.2005.01.031","article-title":"Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study","volume":"118","author":"Frost","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1462-8902.2004.00358.x","article-title":"Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community","volume":"6","author":"Ostgren","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ahj.2008.06.029_bib10","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.06.029_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.06.029_bib12","doi-asserted-by":"crossref","first-page":"786.e1","DOI":"10.1016\/j.ahj.2005.11.004","article-title":"The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events\u2014study design","volume":"151","author":"Ohman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.06.029_bib13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.06.029_bib14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1197\/j.aem.2005.04.018","article-title":"Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice","volume":"12","author":"Laguna","year":"2005","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib15","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.06.029_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2307\/2531823","article-title":"An improved sequentially rejective Bonferroni test procedure","volume":"43","author":"Holland","year":"1987","journal-title":"Biometrics"},{"key":"10.1016\/j.ahj.2008.06.029_bib17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.06.029_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2005.03.073","article-title":"Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial","volume":"46","author":"Beinart","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.06.029_bib20","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.107.688416","article-title":"Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006","volume":"115","author":"Laskey","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.06.029_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.06.029_bib22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib23","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/01.STR.31.11.2616","article-title":"Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study","volume":"31","author":"Tanizaki","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2008.06.029_bib24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archinte.159.10.1118","article-title":"Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk","volume":"159","author":"Kopecky","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-138-10-200305200-00011","article-title":"Lessons from the Stroke Prevention in Atrial Fibrillation trials","volume":"138","author":"Hart","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib26","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.STR.0000035735.49388.4A","article-title":"Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials","volume":"33","author":"Hart","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2008.06.029_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.06.029_bib28","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.06.029_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.thromres.2005.08.007","article-title":"Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"118","author":"Lip","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.ahj.2008.06.029_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial","volume":"37","author":"Sato","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2008.06.029_bib31","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002)","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2008.06.029_bib32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.amjcard.2007.01.052","article-title":"Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes","volume":"99","author":"Testa","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2008.06.029_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1592\/phco.27.5.691","article-title":"Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy","volume":"27","author":"DeEugenio","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"3 Suppl","key":"10.1016\/j.ahj.2008.06.029_bib34","doi-asserted-by":"crossref","first-page":"429S","DOI":"10.1378\/chest.126.3_suppl.429S","article-title":"Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Singer","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2008.06.029_bib35","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.ahj.2004.02.008","article-title":"Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study","volume":"148","author":"Lorenzoni","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.06.029_bib36","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.06.029_bib37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","journal-title":"Arch Intern Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308005504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308005504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:37:28Z","timestamp":1757569048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308005504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0002870308005504"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.06.029","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}